ArticleJournal of dental sciences2026
A preclinical overall evaluation of a novel biomimetic collagen membrane for guided tissue regeneration.
Article in Journal of dental sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nerve Guidance Conduit Prepared from Decellularized Small Intestine for Nerve Repair.Journal of functional biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose: Guided tissue regeneration (GTR) relies on barrier membranes to facilitate periodontal tissue regeneration. Conventional collagen membranes may require chemical crosslinking, which can compromise biological activity. This study evaluated a novel decellularized small intestinal submucosa (dSIS) membrane prepared using an ecofriendly alkyl polyglycoside (APG) technique and compared its biological and regenerative performance with that of a commercial collagen membrane. Materials and methods: APG-treated dSIS membranes were characterized and compared with a commercially available collagen membrane (BioGide®; Geistlich Pharma AG, Wolhusen, Switzerland). Amino acid composition, glycosaminoglycan (GAG) content, and growth factor content were analyzed. In vitro osteoblast adhesion and proliferation were assessed using a human fetal osteoblast cell line. Regenerative efficacy was evaluated in a canine one-wall intrabony defect model using histometric analysis, micro-computed tomography, and fluorochrome labeling. Results: The dSIS membrane preserved the native collagen structure and retained higher levels of GAG and basic fibroblast growth factor than the commercial collagen membrane. Both membranes supported osteoblast adhesion and proliferation without cytotoxic effects. All defects healed uneventfully in vivo. Although no statistically significant differences were observed among groups due to the limited sample size, membrane-treated groups tended to exhibit greater new bone formation than the negative control group. Earlier bone remodeling was observed in the dSIS group. Conclusion: We conclude that APG-treated dSIS demonstrates favorable biocompatibility and regenerative potential comparable to that of a conventional collagen membrane. Retention of native biomolecules may enhance the early bone healing, suggesting that the APG-treated dSIS is a promising alternative for periodontal tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.